13 Panel T-Cup Drug Test Cup – 25/Box (AMP/ BUP/ BZO/ COC/ mAMP/ MDMA/ MTD/ MOP/ OXY/ THC/ ETG/ FEN/ TRA with 3 Adulterants) Forensic Use Only
Original price was: $193.00.$173.75Current price is: $173.75. — or subscribe to save 5%
13-Panel Screening
3 Specimen-Validity Checks
25 test cups per box$6.95 per test at the current sale price
One-step T-Cup for qualitative urine screening of 13 drug and drug-metabolite assays, with creatinine, pH and specific-gravity checks. Drug-screen results are read within 5 minutes. Forensic Use Only.
- Screens AMP, BUP, BZO, COC, mAMP/MET, MDMA, MTD, MOP, OXY, THC, EtG, fentanyl and tramadol
- Includes creatinine, pH and specific-gravity specimen-validity indicators
- Self-contained urine collection and screening cup
- 25 test cups per box
| 1-5 | 6-10 | 11+ |
| $173.75 | $159.85 | $151.16 |
13-Panel T-Cup Drug Test Overview
Reference TDOA-7135A3EFT is a self-contained urine collection and screening cup for the qualitative detection of 13 drug and drug-metabolite assays. The configuration also includes creatinine, pH and specific-gravity indicators for assessing specimen validity. Drug-screen results are read within 5 minutes, and each box contains 25 test cups.
13-Panel Screening
3 Validity Checks
25 Cups per Box
Features and Benefits
13-Panel Screening Configuration
The cup provides a preliminary qualitative result for each assay at the cutoff concentration shown below. The package insert covers multiple T-Cup configurations, so always verify the abbreviations and cutoffs printed on the pouch or box supplied with the product.
| Drug or Target Analyte | Abbreviation | Cutoff |
|---|---|---|
| Amphetamine | AMP | 1,000 ng/mL |
| Buprenorphine | BUP | 10 ng/mL |
| Benzodiazepines | BZO | 300 ng/mL |
| Cocaine metabolite (benzoylecgonine) | COC | 300 ng/mL |
| Methamphetamine | mAMP/MET | 1,000 ng/mL |
| MDMA (Ecstasy) | MDMA | 500 ng/mL |
| Methadone | MTD | 300 ng/mL |
| Morphine | MOP | 300 ng/mL |
| Oxycodone | OXY | 100 ng/mL |
| Marijuana metabolite | THC | 50 ng/mL |
| Ethyl glucuronide | EtG | 500 ng/mL |
| Fentanyl metabolite (norfentanyl) | FEN/FTY | 20 ng/mL |
| Tramadol | TRA | 200 ng/mL |
The cutoff is not a measure of intoxication, impairment, dose or time since use. Detection periods vary with the analyte, frequency and amount of use, metabolism, hydration and other factors; fixed detection windows should not be guaranteed.
Specimen-Validity Indicators
This configuration includes three semi-quantitative indicators that help identify urine specimens with characteristics outside expected ranges. Compare each pad with the color chart supplied with the exact product.
These indicators are screening tools; they do not by themselves identify a specific adulterant or establish intentional tampering. If a result is abnormal, follow the package insert and your organization’s collection and confirmation procedures.
Basic Test Procedure
- Bring the sealed test to room temperature, 18–30°C (64–86°F), before use.
- Open the pouch and collect more than 25 mL of urine directly in the cup.
- Secure the cap, place the cup on a flat surface and start the timer.
- Observe the temperature strip 2–4 minutes after collection. The insert lists 32–38°C (90–100°F) as the acceptable fresh-specimen range.
- Peel back the label from right to left and read the drug-screen results within 5 minutes. Do not interpret drug results after 5 minutes.
- Compare the three specimen-validity pads with the supplied color chart. All adulteration areas may be read at 1–2 minutes; changes after 2 minutes have no diagnostic value.
Always follow the package insert and labeling supplied with the exact product lot.
Result Interpretation
This device provides preliminary screening results only. A more specific analytical method should be used for confirmation. GC/MS or LC/MS is the preferred confirmatory approach. Apply appropriate professional judgment when evaluating any preliminary positive result.
Storage
Store the sealed test at 4–30°C (40–86°F), away from direct sunlight, moisture and heat. Do not freeze. Use the test before the expiration date printed on the pouch or package.
Instructions and Product Documents
Configuration reminder: The package insert covers multiple possible T-Cup configurations. Use the pouch and box labels supplied with reference TDOA-7135A3EFT to identify the assays and specimen-validity indicators in the product received.
Frequently Asked Questions
What does this 13-panel T-Cup screen for?
It screens urine for AMP, BUP, BZO, COC, mAMP/MET, MDMA, MTD, MOP, OXY, THC, EtG, fentanyl and tramadol at the listed cutoff concentrations.
Which specimen-validity indicators are included?
Reference TDOA-7135A3EFT includes creatinine, specific-gravity and pH indicators. Compare them with the color chart supplied with the exact lot.
How quickly are results read?
Read the drug-screen results within 5 minutes and do not interpret them after 5 minutes. Follow the separate timing instructions for the specimen-validity pads.
Is this test OTC or CLIA waived?
No. This EtG, fentanyl and tramadol configuration is identified as Forensic Use Only. It should not be represented as OTC, CLIA waived or FDA cleared.
What does the fentanyl assay detect?
The insert lists norfentanyl as the calibrator for the FTY/FEN assay, with a 20 ng/mL cutoff.
Does a faint test line mean positive?
No. Any visible test line, even a faint one, is interpreted as negative when the control line is present and the test is read at the specified time.
Is a preliminary positive result confirmed?
No. Preliminary positive results require confirmation by a more specific analytical method such as GC/MS or LC/MS.
Can the cup determine when a substance was used?
No. It provides qualitative screening results at defined cutoffs and does not determine dose, impairment or time since use.
How much urine is required?
The package insert instructs the collector to obtain more than 25 mL of urine in the cup.
How many test cups are included?
Each box contains 25 test cups.
Additional information
| Weight | 6 lbs |
|---|---|
| Dimensions | 15 × 15 × 4.5 in |
